Michael Severino is Chairman at AbbVie Inc. (ABBV). They have made 7 open-market trades across 1 company since 2017, most recently 2026-07-28.
CIK 0001609447
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2022-05-23 | 2022-05-25 | $150.90 | $24.1M | -1.6% | +0.5% | -8.3% |
| ABBV | SELL | 2022-05-16 | 2022-05-18 | $154.24 | $61.3M | -2.5% | -8.5% | -5.7% |
| ABBV | SELL | 2022-05-06 | 2022-05-10 | $151.12 | $90.7M | -0.0% | -3.7% | -7.1% |
| ABBV | SELL | 2020-11-04 | 2020-11-06 | $93.61 | $17.0M | +3.1% | +10.5% | +13.4% |
| ABBV | SELL | 2018-08-17 | 2018-08-21 | $97.52 | $4.9M | -1.9% | -5.2% | -8.5% |
| ABBV | SELL | 2018-02-28 | 2018-03-02 | $117.93 | $623K | +4.4% | -19.7% | -13.1% |
| ABBV | SELL | 2017-11-10 | 2017-11-13 | $94.69 | $4.9M | +0.1% | +2.9% | +18.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.